cryptobro4eva

$NOCK TO $0.10 soon COMPUTE MARKETS COMING

I remeber when this man made 100x calls like $HTR and $VRA and $UFO and more. $NOCK is low risk high reward right now.

@DrewDeVilbiss @arkhet Hahaha good one!

@arkhet @CryptoBro4eva Bro NOCKED his head

Dumped all my $TAO for $NOCK More room for growth, community not fractured like Bittensors currently is.

@0zkphilip @AlgodTrading You do realize supply is relative right and what matters is the % that is circulating. 2 bil circulating of 4 bil total is better than 100 mil circulating of 500 mil total... The total amount of tokens is irrelevant.

@AlgodTrading 4B supply. Bro are you joking? Zec is going to 50B MC minimum. Nock is never touching 5B

If you’re in $zec its not too late to rotate into $nock

My $NOCK thesis: If AI cryptos like $TAO pump then NOCK pumps. If they dont - then NOCK still pumps. Why? Because it is a low enough market cap where even someone who doesnt think the market is bullish would still buy and hold due to its Potential ROI. You cant lose.

$TAO bull pennant continues consolidating. Next target: $500 🎯 Just a matter of time, send it!

#TAO Forming a clean #bullish continuation pennant break out confirmation: flip $321 send it $TAO #Trading

$TAO holders. This one is personal. I live with an autoimmune disease. I know what the standard of care looks like. I know what corticosteroids do to your body when you have to rely on them for years. So when @metanova_labs, SN68, announced its new IL-6 target, I paid attention and locked in to what they are doing. Autoimmune disease affects roughly 50 million Americans and around 8% of the global population. Lupus. Rheumatoid arthritis. Crohn’s. MS. Psoriasis. Hashimoto’s. For many patients, long-term steroid use is still the fallback. The side effects are so brutal. Osteoporosis. Cataracts. Glaucoma. Metabolic damage. Adrenal suppression. Weight gain. Mood instability. IL-6 is one of the major inflammatory signals in the body. If you can target it cleanly, you can potentially treat inflammation without destroying everything else around it. That is why IL-6 inhibitors are already a multi-billion dollar market. Actemra. Kevzara. Treatments that can run tens of thousands per patient per year. Now, NOVA is bringing that into Bittensor. Their last nanobody target was PD-L1 for cancer immunotherapy. They received 8,446 unique nanobody submissions from an open decentralized competition. Now, they are moving to IL-6 in partnership with Yalotein, with top submissions eligible for wet lab validation. That is the important part. This is not just AI generating molecules for a dashboard. This is a decentralized virtual screening flowing toward real biologics development. And if it wasn't for biologics, my quality of life would be so different now! NOVA is also making the chemical search competition more exploration focused. Molecules that are too chemically similar will be rejected. That matters because in drug discovery, making 1,000 versions of the same idea is easy. Finding genuinely different scaffolds that actually work is the hard part. That is where real breakthroughs come from. This is why NOVA is different from most AI drug discovery. NOVA is hundreds of miners competing in parallel, paid in $TAO, ranked by results, and pushing the best candidates toward wet lab testing. Cancer, on the one hand. Inflammation on the next. What I am watching now: How many IL-6 submissions come in compared to the 8,446 from PD-L1. Whether the new exploration rules increase true chemical diversity. Most importantly, what happens in wet lab validation with Yalotein. Because that is where decentralized AI either proves itself in physical reality or it does not. The people who need better autoimmune treatments are not thinking about crypto. They are in waiting rooms or emergency rooms. They are trying to work through pain. They are choosing between rent and the medication. They are hoping for something better, period. If decentralized incentive driven discovery can shave years off the timeline or help lower the cost of better therapies, the impact is not just measured in token price. It is measured in lives and quality of life itself. That is why I care about this network. It's not just a chart. The work. NOVA is one subnet. There are many more. Each one is writing its own version of this incredible mission while the market argues about everything else. I will be watching IL-6 closely. Personally and otherwise. $TAO

@CryptoGodJohn Or Wemby and Castle they got a deep squad

Harper & Wemby are going to be the modern day Shaq & Kobe for years to come

@CryptoWizardd Same for $TAO

The way those $ZEC dips getting eaten says enough Much higher in 2026

Bottom was 234 a few days later yes I was off a bit but iamgine missing out on an a generational entry. $TAO

@ElonTrades Brother I think you are shadow banned I dont ever see you on my feed anymore.

We’re up 14x on $POD, probably going to go down as one of top hidden gem finds of the year. Why do I keep doing what I do? For the love of the game.

Price for $KTA at 13 cents now be patient. 10 cents is coming then you buy and flip it for a quick 50% profits or maybe even 2x if the team has any decent news.

False - layer 1's like $SUI $OSMO $SEI $TON have been doing well. $KTA hype cycle is done

@signalthevoid Bought keeta first week sold after a 100x during its hype cycle which is done now. All you people who came late and think you are early are delusional.

Dont trust anything regarding $KTA - remmeber they said they had 6 to 7 household name partners and still haven't revealed even 1. Sub 10 cents incoming

@SiemReap_Dude What several? Name one that's an actual partner vs keeta using the tech. A partnership means both sides benefit.

@CryptoBro4eva Well that's bullshit, they've revealed several since I've owned this in just the last 6 months. Where the F is this fud coming from?

@Vlad2082336 Lol stripe and visa funny

@CryptoBro4eva You’re forgetting about Stripe and Visa

$TAO is on a moon mission. Next target: $500 ✅